Mereo BioPharma (MREO) Amortizatization of Intangibles (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Amortizatization of Intangibles for 3 consecutive years, with $486000.0 as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles rose 341.82% to $486000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $527000.0 through Dec 2025, up 20.32% year-over-year, with the annual reading at $527000.0 for FY2025, 20.32% up from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $486000.0 at Mereo BioPharma, up from -$221000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $486000.0 in Q4 2025, with the low at -$221000.0 in Q3 2025.
  • Average Amortizatization of Intangibles over 3 years is $121666.7, with a median of $111000.0 recorded in 2024.
  • Peak annual rise in Amortizatization of Intangibles hit 341.82% in 2025, while the deepest fall reached 297.32% in 2025.
  • Over 3 years, Amortizatization of Intangibles stood at $215000.0 in 2023, then plummeted by 48.84% to $110000.0 in 2024, then skyrocketed by 341.82% to $486000.0 in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $486000.0, -$221000.0, and $136000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.